Response by Kumbhani et al to Letters Regarding Article, "association between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted with Heart Failure: Insights from Get with the Guidelines-Heart Failure"

Dharam J. Kumbhani; Gregg C. Fonarow; Paul A. Heidenreich; Phillip J. Schulte; Di Lu; Adrian Hernandez; Clyde Yancy; Deepak L. Bhatt

doi:10.1161/CIRCULATIONAHA.118.036250

Response by Kumbhani et al to Letters Regarding Article, "association between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted with Heart Failure: Insights from Get with the Guidelines-Heart Failure"

Dharam J. Kumbhani, Gregg C. Fonarow, Paul A. Heidenreich, Phillip J. Schulte, Di Lu, Adrian Hernandez, Clyde Yancy, Deepak L. Bhatt

Medicine, Cardiology Division

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	2306-2307
Number of pages	2
Journal	Circulation
Volume	138
Issue number	20
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.118.036250
State	Published - Nov 13 2018

Funding

Dr Kumbhani has received honoraria from the American College of Cardiology. Dr Fonarow has received research funding from the National Institutes of Health and is a consultant for Amgen, Janssen, Medtronic, Novartis, and St Jude Medical. Dr Bhatt is on the Advisory Board of Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, and Regado Biosciences; is on the Board of Directors of Boston VA Research Institute and the Society of Cardiovascular Patient Care; is a chair of the American Heart Association Quality Oversight Committee; is on the Data Monitoring Committees of the Cleveland Clinic, Duke Clinical Research Institute, Harvard Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine, and Population Health Research Institute; has received honoraria from the American College of Cardiology (senior associate editor, Clinical Trials and News, ACC.org), Belvoir Publications (editor-in-chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), Harvard Clinical Research Institute (clinical trial steering committee), HMP Communications (editor-in-chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (guest editor, associate editor), Population Health Research Institute (clinical trial steering committee), Slack Publications (chief medical editor, Cardiology Today\u2019s Intervention), Society of Cardiovascular Patient Care (secretary/treasurer), and WebMD (CME steering committees); is a deputy editor of Clinical Cardiology; is Chair of the NCDR-ACTION Registry Steering Committee; is Chair of the VA CART Research and Publications Committee; has received research funding from Amarin, Am-gen, AstraZeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Ironwood, Ischemix, Lilly, Medtronic, Pfizer, Roche, Sanofi Aventis, and the Medicines Company; has received royalties from Elsevier (editor, Cardiovascular Intervention: A Companion to Braunwald\u2019s Heart Disease); is a site coinvestigator for Biotronik, Boston Scientific, and St Jude Medical (now Abbott); is a trustee for American College of Cardiology; and has received unfunded research funding from FlowCo, Merck, PLx Pharma, and Takeda. The other authors declare no conflicts of interest.

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIRCULATIONAHA.118.036250

Cite this

Kumbhani, D. J., Fonarow, G. C., Heidenreich, P. A., Schulte, P. J., Lu, D., Hernandez, A., Yancy, C., & Bhatt, D. L. (2018). Response by Kumbhani et al to Letters Regarding Article, "association between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted with Heart Failure: Insights from Get with the Guidelines-Heart Failure". Circulation, 138(20), 2306-2307. https://doi.org/10.1161/CIRCULATIONAHA.118.036250

@article{516c70a77bb244b1ac9565a904d4de9b,

title = "Response by Kumbhani et al to Letters Regarding Article, {"}association between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted with Heart Failure: Insights from Get with the Guidelines-Heart Failure{"}",

author = "Kumbhani, {Dharam J.} and Fonarow, {Gregg C.} and Heidenreich, {Paul A.} and Schulte, {Phillip J.} and Di Lu and Adrian Hernandez and Clyde Yancy and Bhatt, {Deepak L.}",

note = "Funding Information: Dr Kumbhani has received honoraria from the American College of Cardiology. Dr Fonarow has received research funding from the National Institutes of Health and is a consultant for Amgen, Janssen, Medtronic, Novartis, and St Jude Medical. Dr Bhatt is on the Advisory Board of Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, and Regado Biosciences; is on the Board of Directors of Boston VA Research Institute and the Society of Cardiovascular Patient Care; is a chair of the American Heart Association Quality Oversight Committee; is on the Data Monitoring Committees of the Cleveland Clinic, Duke Clinical Research Institute, Harvard Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine, and Population Health Research Institute; has received honoraria from the American College of Cardiology (senior associate editor, Clinical Trials and News, ACC.org), Belvoir Publications (editor-in-chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), Harvard Clinical Research Institute (clinical trial steering committee), HMP Communications (editor-in-chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (guest editor, associate editor), Population Health Research Institute (clinical trial steering committee), Slack Publications (chief medical editor, Cardiology Today{\textquoteright}s Intervention), Society of Cardiovascular Patient Care (secretary/treasurer), and WebMD (CME steering committees); is a deputy editor of Clinical Cardiology; is Chair of the NCDR-ACTION Registry Steering Committee; is Chair of the VA CART Research and Publications Committee; has received research funding from Amarin, Am-gen, AstraZeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Ironwood, Ischemix, Lilly, Medtronic, Pfizer, Roche, Sanofi Aventis, and the Medicines Company; has received royalties from Elsevier (editor, Cardiovascular Intervention: A Companion to Braunwald{\textquoteright}s Heart Disease); is a site coinvestigator for Biotronik, Boston Scientific, and St Jude Medical (now Abbott); is a trustee for American College of Cardiology; and has received unfunded research funding from FlowCo, Merck, PLx Pharma, and Takeda. The other authors declare no conflicts of interest.",

year = "2018",

month = nov,

day = "13",

doi = "10.1161/CIRCULATIONAHA.118.036250",

language = "English (US)",

volume = "138",

pages = "2306--2307",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "20",

}

Kumbhani, DJ, Fonarow, GC, Heidenreich, PA, Schulte, PJ, Lu, D, Hernandez, A, Yancy, C & Bhatt, DL 2018, 'Response by Kumbhani et al to Letters Regarding Article, "association between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted with Heart Failure: Insights from Get with the Guidelines-Heart Failure"', Circulation, vol. 138, no. 20, pp. 2306-2307. https://doi.org/10.1161/CIRCULATIONAHA.118.036250

Response by Kumbhani et al to Letters Regarding Article, "association between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted with Heart Failure: Insights from Get with the Guidelines-Heart Failure". / Kumbhani, Dharam J.; Fonarow, Gregg C.; Heidenreich, Paul A. et al.
In: Circulation, Vol. 138, No. 20, 13.11.2018, p. 2306-2307.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Response by Kumbhani et al to Letters Regarding Article, "association between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted with Heart Failure

T2 - Insights from Get with the Guidelines-Heart Failure"

AU - Kumbhani, Dharam J.

AU - Fonarow, Gregg C.

AU - Heidenreich, Paul A.

AU - Schulte, Phillip J.

AU - Lu, Di

AU - Hernandez, Adrian

AU - Yancy, Clyde

AU - Bhatt, Deepak L.

N1 - Funding Information: Dr Kumbhani has received honoraria from the American College of Cardiology. Dr Fonarow has received research funding from the National Institutes of Health and is a consultant for Amgen, Janssen, Medtronic, Novartis, and St Jude Medical. Dr Bhatt is on the Advisory Board of Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, and Regado Biosciences; is on the Board of Directors of Boston VA Research Institute and the Society of Cardiovascular Patient Care; is a chair of the American Heart Association Quality Oversight Committee; is on the Data Monitoring Committees of the Cleveland Clinic, Duke Clinical Research Institute, Harvard Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine, and Population Health Research Institute; has received honoraria from the American College of Cardiology (senior associate editor, Clinical Trials and News, ACC.org), Belvoir Publications (editor-in-chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), Harvard Clinical Research Institute (clinical trial steering committee), HMP Communications (editor-in-chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (guest editor, associate editor), Population Health Research Institute (clinical trial steering committee), Slack Publications (chief medical editor, Cardiology Today’s Intervention), Society of Cardiovascular Patient Care (secretary/treasurer), and WebMD (CME steering committees); is a deputy editor of Clinical Cardiology; is Chair of the NCDR-ACTION Registry Steering Committee; is Chair of the VA CART Research and Publications Committee; has received research funding from Amarin, Am-gen, AstraZeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Ironwood, Ischemix, Lilly, Medtronic, Pfizer, Roche, Sanofi Aventis, and the Medicines Company; has received royalties from Elsevier (editor, Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease); is a site coinvestigator for Biotronik, Boston Scientific, and St Jude Medical (now Abbott); is a trustee for American College of Cardiology; and has received unfunded research funding from FlowCo, Merck, PLx Pharma, and Takeda. The other authors declare no conflicts of interest.

PY - 2018/11/13

Y1 - 2018/11/13

UR - http://www.scopus.com/inward/record.url?scp=85058918812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058918812&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.118.036250

DO - 10.1161/CIRCULATIONAHA.118.036250

M3 - Letter

C2 - 30571514

AN - SCOPUS:85058918812

SN - 0009-7322

VL - 138

SP - 2306

EP - 2307

JO - Circulation

JF - Circulation

IS - 20

ER -

Kumbhani DJ, Fonarow GC, Heidenreich PA, Schulte PJ, Lu D, Hernandez A et al. Response by Kumbhani et al to Letters Regarding Article, "association between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted with Heart Failure: Insights from Get with the Guidelines-Heart Failure". Circulation. 2018 Nov 13;138(20):2306-2307. doi: 10.1161/CIRCULATIONAHA.118.036250

Response by Kumbhani et al to Letters Regarding Article, "association between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted with Heart Failure: Insights from Get with the Guidelines-Heart Failure"

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this